We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Siemens Healthineers Showcases Atellica Solution at AACC 2017

By LabMedica International staff writers
Posted on 07 Aug 2017
Siemens Healthineers (Erlangen, Germany), the separately managed healthcare business of Siemens AG, showcased the Atellica Solution – flexible, scalable, automation-ready immunoassay and chemistry analyzers for laboratory diagnostics – at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo, the world’s largest exposition for clinical laboratory products and services.

Siemens Healthineers offers a comprehensive portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. More...
The company was among over 750 exhibitors who displayed pioneering diagnostic technology, including the latest in mobile health, molecular diagnostics, mass spectrometry, point-of-care (POC), and automation at the 2017 AACC Clinical Lab Expo held at the San Diego Convention Center from August 1-3.

The recently 510(k)-cleared Atellica Solution is comprised of sample management and immunoassay and chemistry analyzer components. It can combine up to 10 components into more than 300 customizable configurations – including linear, L and U shapes. With an immunoassay analyzer that runs up to 440 tests per hour, the Atellica Solution is suitable for mid-and high-volume labs. The product was displayed as a stand-alone system at AACC 2017 and connected to Aptio Automation to demonstrate a comprehensive multi-disciplinary solution.

“Siemens Healthineers is driving healthcare forward in the digital age by delivering fast and easy interaction between data and knowledge, to go along with our complete in vivo and in vitro offerings,” said Michael Reitermann, Chief Operating Officer, Siemens Healthineers.
Siemens Healthineers also exhibited the Atellica Diagnostics IT family of products, which includes connectivity management, data management, inventory management, process management and clinical decision support for multi-site laboratories seeking real-time analytics to improve workflow and efficiency. Atellica Diagnostics IT features customizable parameters, performance-monitoring capabilities, and centralized control over the day-to-day laboratory operations to improve business and clinical outcomes.

“FDA clearance for the Atellica Solution opens the door for us to change the game in laboratory diagnostics with a revolutionary platform designed by customers for customers,” said Franz Walt, President, Laboratory Diagnostics, Siemens Healthineers. “Combined with the Atellica Solution, our highly integrated Atellica Diagnostics IT will simplify lab workflows to meet increasing testing demand.”

The company also showcased its complete POC informatics portfolio with offerings for secure connectivity to more than 160 devices from over 40 vendors. The solutions are designed to streamline operations and centrally manage all POCT devices.

“Open connectivity, regardless of the manufacturer, for point-of-care instruments addresses key pain points that previously challenged the implementation of point-of-care testing,” said Peter Koerte, President, Point of Care Diagnostics, Siemens Healthineers. “Further, the latest advances in connectivity provide POC coordinators valuable data for better decision-making to support improved patient outcomes.”

Siemens Healthineers’ informatics offerings include RAPIDComm Data Management System for managing and controlling POC testing programs, POCcelerator Software, which connects POCT devices from all manufacturers to a hospital’s IT system, and UniPOC Software, which seamlessly connects and manages POC devices from numerous manufacturers through a single enterprise platform for laboratories that prefer a vendor-independent approach.

Additionally, Siemens Healthineers celebrated the US launch of Xprecia Stride, a handheld portable coagulation analyzer for Prothrombin Time International Normalized Ratio (PT/INR) testing for point-of-care monitoring and management of oral anticoagulation therapy with warfarin, a vitamin K antagonist.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.